Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–4 of 4 results
Advanced filters: Author: Aoisha Hoyle Clear advanced filters
  • The prevalence of centrosome amplification (CA) and the genomic landscape of chromosomal instability in high-grade serous ovarian carcinoma (HGSOC) remain to be explored. Here the authors suggest CA as a potential driver of tumour evolution and a biomarker for treatment response in HGSOC.

    • Carolin M. Sauer
    • James A. Hall
    • James D. Brenton
    ResearchOpen Access
    Nature Communications
    Volume: 14, P: 1-20
  • The authors identify copy number signatures from shallow whole-genome sequencing of high-grade serous ovarian cancer (HGSOC) cases. HGSOC comprises a continuum of genomes shaped by multiple mutational processes that result in genomic aberration.

    • Geoff Macintyre
    • Teodora E. Goranova
    • James D. Brenton
    Research
    Nature Genetics
    Volume: 50, P: 1262-1270
  • The secretome from cancer and stromal cells contributes to the creation of a microenvironment, which in turn contributes to invasion and angiogenesis. Here, the authors compare the secretomes of immortalized normal fibroblasts and cancer-derived fibroblast and identify CLIC3 as a driver of cancer progression.

    • Juan R. Hernandez-Fernaud
    • Elena Ruengeler
    • Sara Zanivan
    ResearchOpen Access
    Nature Communications
    Volume: 8, P: 1-17
  • Mannose reduces the growth of tumour cells by impairing the metabolism of glucose, and enhances cell death when used in combination with conventional chemotherapy.

    • Pablo Sierra Gonzalez
    • James O’Prey
    • Kevin M. Ryan
    Research
    Nature
    Volume: 563, P: 719-723